Position in GH
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$262,852
New position
Shares Held
1,752
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#420
of 594 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Concurrent Investment Advisors, LLC holds $33,542,356 across 16 Diagnostics & Research names. GH ranks #15 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
22,699 | $11,380,370 | |
| 2 | ICLR |
Icon PLC
|
36,482 | $6,337,287 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
13,880 | $2,681,893 | |
| 4 | DHR |
Danaher Corp /De/
|
11,715 | $2,231,472 | |
| 5 | NTRA |
Natera, Inc.
|
7,639 | $2,073,606 | |
| 6 | GRAL |
GRAIL, Inc.
|
30,253 | $2,065,371 | |
| 7 | LH |
Labcorp Holdings Inc.
|
5,369 | $1,503,320 | |
| 8 | DGX |
Quest Diagnostics Inc
|
5,183 | $1,098,536 |
All Filings in GH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $262,852 | 1,752 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||